Cargando…
A Real-World Observational Study of Gla-300 in Adults with Type 2 Diabetes Who Fast During Ramadan in the South Asia Region: A Subgroup Analysis of the ORION Study
INTRODUCTION: In this ORION study subgroup analysis, the safety and effectiveness of insulin glargine 300 U/mL (Gla-300) was evaluated in people from the South Asia region with type 2 diabetes mellitus (T2DM) before, during, and after Ramadan, in a real-world setting. METHODS: The ORION study was a...
Autores principales: | Hassanein, Mohamed, Sahay, Rakesh, Hasan, Mohammad I., Hussain, Arshad, Mittal, Vinod, Mohammed, Riyaz, Shaikh, Zaman, Farishta, Faraz, Mohanasundaram, Senthilnathan, Naqvi, Mubarak, Nair, Arjun, Ali, Zubair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991272/ https://www.ncbi.nlm.nih.gov/pubmed/35286607 http://dx.doi.org/10.1007/s13300-022-01234-y |
Ejemplares similares
-
SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
por: Hassanein, Mohamed, et al.
Publicado: (2020) -
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study
por: Malik, Rayaz A., et al.
Publicado: (2022) -
Orion
por: Glass, Philip, et al.
Publicado: (2005) -
Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11
por: Koenig, Wolfgang, et al.
Publicado: (2023) -
Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review
por: Ghosh, Sujoy, et al.
Publicado: (2023)